Literature DB >> 16815281

Effects of topical antiglaucoma application on conjunctival impression cytology specimens.

Samin Hong1, Christopher Seungkyu Lee, Kyoung Yul Seo, Gong Je Seong, Young Jae Hong.   

Abstract

PURPOSE: To evaluate the changes in conjunctival impression cytology specimens from patients receiving various topical antiglaucoma medications.
DESIGN: Cross-sectional comparative study.
METHODS: Impression cytology specimens were obtained from the eyes taking no topical medication (n = 20) and from the eyes taking various antiglaucoma medications (timolol n = 34; latanoprost n = 40; dorzolamide n = 32; timolol + latanoprost n = 30; timolol + dorzolamide n = 34). Specimens were graded on a scale of zero to three according to Nelson's method.
RESULTS: Cytology scores were significantly higher in the medication group than the control group. Mean cytology scores of the control, timolol, latanoprost, dorzolamide, timolol + latanoprost, and timolol + dorzolamide group were 0.20, 1.62, 2.00, 1.75, 2.13, and 2.44, respectively. Among the medication groups, cytology scores were significantly lower in the monotherapy group than the fixed-combination therapy group.
CONCLUSIONS: Various topical antiglaucoma medications induce a significant degree of squamous metaplasia. Conjunctival surface could be altered after the long-term use of antiglaucoma medication.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16815281     DOI: 10.1016/j.ajo.2006.02.056

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  7 in total

1.  [Preservatives from the perspective of glaucoma surgery].

Authors:  H Thieme; K K van der Velden
Journal:  Ophthalmologe       Date:  2012-11       Impact factor: 1.059

2.  Effects of antiglaucoma drugs on the ocular surface in rabbits: a fixed-combination drug versus two concomitant drugs.

Authors:  Hyun Kyung Cho; Myoung Hee Park; Jung Il Moon
Journal:  Jpn J Ophthalmol       Date:  2011-09-09       Impact factor: 2.447

3.  Glaucoma medical treatment as a predictor of XEN45 subconjunctival gel implant hypotensive efficacy.

Authors:  Carmen Méndez-Hernández; Carlos Palomino-Bautista; Ramón Torres-Imaz; Pilar Peña-Urbina; Lucía Perucho-González; Julián García-Feijoo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-08-20       Impact factor: 3.535

4.  Differential pharmacology and clinical utility of preservative-free tafluprost in the treatment of ocular hypertension and glaucoma.

Authors:  Sıtkı Samet Ermiş
Journal:  Clin Ophthalmol       Date:  2012-05-07

5.  Conjunctival structure of glaucomatous eyes treated with anti-glaucoma eye drops: a cross-sectional study using anterior segment optical coherence tomography.

Authors:  Makoto Gozawa; Yoshihiro Takamura; Kentaro Iwasaki; Shogo Arimura; Masaru Inatani
Journal:  BMC Ophthalmol       Date:  2020-06-19       Impact factor: 2.209

6.  Effect of latanoprost and timolol on the histopathology of the human conjunctiva.

Authors:  N Terai; U Schlötzer-Schrehardt; J Lampel; A G Böhm; C Rummelt; E Schmidt; L E Pillunat
Journal:  Br J Ophthalmol       Date:  2008-10-29       Impact factor: 4.638

7.  The effects of topical antiglaucoma drugs as monotherapy on the ocular surface: a prospective study.

Authors:  Sevda Aydin Kurna; Semih Acikgoz; Ahmet Altun; Nurver Ozbay; Tomris Sengor; Osman Okan Olcaysu
Journal:  J Ophthalmol       Date:  2014-06-09       Impact factor: 1.909

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.